BIOCYTOGEN-B

2315
39.9803.43% ( -1.420 )
Delay Closed: Nov 16, 16:08:11

Financials

Q3 FY2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: BIOCYTOGEN-B(02315) the Revenue is 539.8 M (+54.37%);the EBIT is 39.1 M (-18.57%);the EPS is 0.185 (-0.84%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.54B54.37%
----
----
EBIT
0.04B18.57%
----
----
EPS
0.18470.84%
----
----

Upcoming earnings report - FY2026 Annual Earning Release

Available dateMar 25, 2027
Estimate Revenue2.257 B
Estimate EBIT--
Estimate EPS0.9985

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly